HEALTH

Wyeth reports dip in revenues; attributes flux to upheaval over kids’ cough-cold dosing

BY Michael Johnsen

MADISON, N.J. Net revenues for Wyeth’s Worldwide Consumer Healthcare division fell 5 percent for the third quarter ending Sept. 30, the company reported Wednesday morning, primarily to a decrease in sales of Robitussin and Advil. Sales of Advil were down 7 percent to $165 million; and while Robitussin sales were not broken out specifically, the brand is one of several that have been negatively impacted over the confusion on whether or not pediatric cough-cold are safe and effective.

“The cough-cold market is changing considerably as illustrated” by the recent announcements from the Consumer Healthcare Products Association around voluntary label changes advising consumers not to give cough-cold medicines to children under the age of four and the January 2008 Food and Drug Administration announcement banning the marketing of these medicines to children under the age of two, commented Greg Norden, Wyeth senior vice president and chief financial officer, this morning during a call with analysts. Wyeth expects this business to rebound in the coming season, Norden noted.

“We’ve also launched a new product, Robitussin DM” to take advantage of a growing adult market, commented Cavan Redmond, president of Wyeth Consumer Healthcare.

The company’s dietary supplement franchise proved positive, however. Sales of Centrum were up 7 percent to $186 million.

Wyeth completed its acquisition of the Thermacare product line from Procter & Gamble last month and is expected to enhance Wyeth’s global position in pain management, the company stated.

Overall, worldwide net revenue increased 4 percent, to $5.8 billion, for the quarter. Excluding the favorable impact of foreign exchange, worldwide net revenue increased 2 percent.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Dossia, Google team with Continua in growing Web healthcare information resources

BY Michael Johnsen

PORTLAND, Ore. Continua Health Alliance on Tuesday announced the addition of new members Dossia, a non-profit consortium focused on empowering consumers with personally-controlled health records, and Google, a search and information management companies that has created a healthcare online destination.

Since its launch in 2006, Continua has grown to include 170 of the world’s most successful technology companies, medical and fitness device manufacturers, and healthcare organizations working across three key markets: chronic disease management, independent aging and proactive health and wellness.

“Consumers are ready to adopt healthcare technology, such as personally-controlled health records and home health monitoring devices,” stated Colin Evans, Dossia president and chief executive officer. “Individuals with a more complete picture of their health have the opportunity to make smarter, more informed health decisions, to stay healthier and help lower out-of-control costs. Dossia is looking forward to working with Continua and its members to create open healthcare solutions.”

“Google ardently supports the concepts of interoperability, data portability, and open standards, so it was a natural fit for us to join the Continua Alliance,” added Jerry Lin, product manager for Google Health. “Our work with Continua will help us continue to develop integration with various home monitoring devices to ensure that data can be uploaded from these devices and securely stored in Google Health.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

LifeScan launches Global Diabetes Handprint campaign

BY Michael Johnsen

MILPITAS, Calif. LifeScan, the maker of OneTouch Brand Blood Glucose Monitoring Systems for people with diabetes, on Monday launched its Global Diabetes Handprint (www.DiabetesHandprint.com) initiative, developed in collaboration with the Diabetes Hands Foundation.

The Global Diabetes Handprint is inviting people with diabetes to submit images of their hand, decorated with words and graphics depicting their personal expressions about living with diabetes. The images will in turn be showcased on the Diabetes Handprint Web site, encouraging visitors to share their own hand images.

“The idea behind the original ‘Word In Your Hand’ project was to inspire people with diabetes to connect with one another and not feel so isolated,” Manny Hernandez, president of the Diabetes Hands Foundation said. “Now, the Global Diabetes Handprint expands this concept by reaching more people than ever before, encouraging them in their daily struggle with diabetes while giving back to the diabetes community with company donations.”

For each image submitted between now and March 31, OneTouch will donate $5 up to a maximum of $250,000 for diabetes charities.

The funds generated by participation in the Global Diabetes Handprint will be donated to the Diabetes Education and Camping Association to support children’s diabetes camps and to Taking Control of Your Diabetes to support adult educational and motivational conferences for people with diabetes, those at risk and their loved ones.2 Participants will designate which organization—DECA or TCOYD—will receive the donation associated with their image submission.

As the Diabetes Handprint Project progresses, the images posted by site visitors will be combined to create an interactive, hand-shaped mosaic. Visitors to www.DiabetesHandPrint.com will be able to search for individual images or view them by moving their cursor across the mosaic. Additionally, there will be a featured image, which will be updated regularly. OneTouch will also select five individuals and their images by Dec. 31 to later feature in a national promotional campaign for the Global Diabetes Handprint project.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?